Investorideas.com newswire, breaking biotechnology and pharma news

Friday, July 10, 2020

#DefenseStocks Updates: Patriot One (TSX: $PAT.TO) (OTCQX: $PTOTF) Partners with ecoMine Technologies to advance on-the-spot pathogen screening technology; @Patriot1tech


#DefenseStocks Updates: Patriot One (TSX: $PAT.TO) (OTCQX: $PTOTF) Partners with ecoMine Technologies to advance on-the-spot pathogen screening technology; @Patriot1tech

TORONTO, ON  July 10, 2020 –  Investorideas.com Newswire and Homelanddefensestocks.comSecurity/Covid 19 stock news -Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), is pleased to announce a development partnership with ecoMine Technologies Corporation (ecoMine) to  advance ecoMine’s innovative, low-cost, on-the-spot pathogen screening technology.  ecoMine’s technology platform has significant potential in this current pandemic, (especially when it comes to enabling the safe return to work across multiples sectors of the economy) as well as a broad range of other pathogen detection applications beyond COVID19.  

Read this news featuring Patriot One in full at

ecoMine has been selected by Canada’s Digital Technology Supercluster (the “ Supercluster”) as a feasibility project under its  recent COVID19 program, to enable the proof of concept  development and prototyping of COVID19 antigen screens, integrated into a secure digital assurance platform to provide a holistic approach to workplace health and public safety.  

“We are delighted to be working with ecoMine, which is allowing us to carry out our mission to create safer communities by detecting threats facing our global citizens,” expressed Martin Cronin, CEO of Patriot One.  “This-on-the-spot screening solution – ecoScreen - is highly innovative and has the potential to become a significant element within our expanding PATSCAN Platform and will assist our resellers and their end client users to build safe environments within their facilities.”

“Partnering with Patriot One Technologies on this Covid19 Program was ideal,” said Rob Greene, CEO of ecoMine.  “Patriot One is an AI-driven technology firm that has the deep technical expertise to help us create secure data architectures based on our on-the-spot-screening solution, and they have a powerful network of security system integrators able to work with property owners to create safe, secure locations for their staff, customers and partners.”

Respectfully

“Robert Greene”                                                        
Robert Greene, CEO
ecoMine Technologies
                                                 
“Martin Cronin”
Martin Cronin, CEO
Patriot One Technologies

About Patriot One Technologies Inc.
Patriot Ones' mission is to deliver innovative threat detection and counter-terrorism solutions for safer communities. Our PATSCAN™ Multi-Sensor Covert Threat Detection Platform provides a network of advanced sensor technologies with powerful next generation AI/machine learning software. The network can be covertly deployed from far perimeter to interiors across multiple weapons-restricted facilities. The PATSCAN™ platform identifies and reports threats wherever required; car park, building approach, employee & public entryways and inside the facilities. Each solution in the platform identifies weapons, related threats or disturbances, or potential health and safety threats for immediate security response. Our motto Deter, Detect and Defend is based on the belief that widespread use of the PATSCAN™ platform will act as an effective deterrent to diminish the epidemic of active threats around the globe. For more information, visit: www.patriot1tech.com or follow us on Twitter and Facebook.

About EcoMine
EcoMine is a Vancouver based start-up that was established in 2017 to explore novel peptide-based chemistries for a variety of sensing, industrial and mineral processing applications.  Its proprietary technology uses synthetic biology to create purpose-built, low-cost environmentally benign biochemical reagents with high binding affinities and high selectivity.

About Digital Technology Supercluster: 
The Digital Technology Supercluster is led by global companies such as  Microsoft, Telus, Teck Resources Limited, Mosaic Forest Management, Lululemon, LifeLabs,  MDA,  and Terramera, and tech industry leaders such as 1Qbit, D-Wave Systems, Finger Food Advanced Technology Group, Sanctuary AI,  and LlamaZOO. Members also include BC’s post-secondary institutions such as Emily Carr University of Art + Design, British Columbia Institute of Technology, University of British Columbia and Simon Fraser University.  A full list of Members can be found here.

About the COVID-19 Program:
The COVID-19 Program funds projects that contribute to improving the health and safety of Canadians, supporting Canada’s ability to address issues created by the COVID-19 outbreak.  In addition, these projects will build expertise and capacity to address and anticipate issues that may arise in future health crises. More information can be found here.

For further information, please contact:

Patriot One Inquiries
info@patriot1tech.com

Investor Relations
John Martin, Patriot One
+1 (888) 728-1332
johnm@patriot1tech.com

Media Contacts:
Scott Ledingham, Patriot One
+1-613-806-7135
scott@prmedianow.com

Digital Technology Supercluster
Elysa Darling
587-890-9833

CAUTIONARY DISCLAIMER STATEMENT:
No securities exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release.  This news release contains forward-looking statements relating to system sales, product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects”, “believes”, and similar expressions.  All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties.  There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.  Important factors that could cause actual results to differ materially from the Company's expectations include counterparty default and other risks detailed from time to time in the filings made by the Company with securities regulations.  The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect.  Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company.  The reader is cautioned not to place undue reliance on any forward-looking information.  Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.  Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.  The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements only as expressly required by applicable law.

Neither the Toronto Stock Exchange (TSX) nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring TSX: PAT is a paid for news release on Investorideas.com ($750) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
About Investorideas.com

Sign up for free stock news alerts at Investorideas.com










 Get more Covid19 Investor Ideas – news, articles and stock directories 


Thursday, July 9, 2020

#Security/ #Covid19 News - Patriot One (TSX: $PAT.TO) (OTCQX: $PTOTF) Partners with ecoMine Technologies via Canada’s Digital Technology Supercluster’s Covid19 Program; @Patriot1tech


#Security/ #Covid19 News - Patriot One (TSX: $PAT.TO) (OTCQX: $PTOTF) Partners with ecoMine Technologies via Canada’s Digital Technology Supercluster’s Covid19 Program; @Patriot1tech



TORONTO, ON  July 9, 2020 –  Investorideas.com Newswire and Homelanddefensestocks.com –Security/Covid 19 stock news -Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), is pleased to announce a development partnership with ecoMine Technologies Corporation (ecoMine) to  advance ecoMine’s innovative, low-cost, on-the-spot pathogen screening technology.  ecoMine’s technology platform has significant potential in this current pandemic, (especially when it comes to enabling the safe return to work across multiples sectors of the economy) as well as a broad range of other pathogen detection applications beyond COVID19.  


ecoMine has been selected by Canada’s Digital Technology Supercluster (the “ Supercluster”) as a feasibility project under its  recent COVID19 program, to enable the proof of concept  development and prototyping of COVID19 antigen screens, integrated into a secure digital assurance platform to provide a holistic approach to workplace health and public safety.  

“We are delighted to be working with ecoMine, which is allowing us to carry out our mission to create safer communities by detecting threats facing our global citizens,” expressed Martin Cronin, CEO of Patriot One.  “This-on-the-spot screening solution – ecoScreen - is highly innovative and has the potential to become a significant element within our expanding PATSCAN Platform and will assist our resellers and their end client users to build safe environments within their facilities.”

“Partnering with Patriot One Technologies on this Covid19 Program was ideal,” said Rob Greene, CEO of ecoMine.  “Patriot One is an AI-driven technology firm that has the deep technical expertise to help us create secure data architectures based on our on-the-spot-screening solution, and they have a powerful network of security system integrators able to work with property owners to create safe, secure locations for their staff, customers and partners.”

Respectfully

“Robert Greene”                                                        
Robert Greene, CEO
ecoMine Technologies
                                                 
“Martin Cronin”
Martin Cronin, CEO
Patriot One Technologies

About Patriot One Technologies Inc.
Patriot Ones' mission is to deliver innovative threat detection and counter-terrorism solutions for safer communities. Our PATSCAN™ Multi-Sensor Covert Threat Detection Platform provides a network of advanced sensor technologies with powerful next generation AI/machine learning software. The network can be covertly deployed from far perimeter to interiors across multiple weapons-restricted facilities. The PATSCAN™ platform identifies and reports threats wherever required; car park, building approach, employee & public entryways and inside the facilities. Each solution in the platform identifies weapons, related threats or disturbances, or potential health and safety threats for immediate security response. Our motto Deter, Detect and Defend is based on the belief that widespread use of the PATSCAN™ platform will act as an effective deterrent to diminish the epidemic of active threats around the globe. For more information, visit: www.patriot1tech.com or follow us on Twitter and Facebook.

About EcoMine
EcoMine is a Vancouver based start-up that was established in 2017 to explore novel peptide-based chemistries for a variety of sensing, industrial and mineral processing applications.  Its proprietary technology uses synthetic biology to create purpose-built, low-cost environmentally benign biochemical reagents with high binding affinities and high selectivity.

About Digital Technology Supercluster: 
The Digital Technology Supercluster is led by global companies such as  Microsoft, Telus, Teck Resources LimitedMosaic Forest Management, Lululemon, LifeLabs,  MDA,  and Terramera, and tech industry leaders such as 1Qbit, D-Wave SystemsFinger Food Advanced Technology Group, Sanctuary AI,  and LlamaZOO. Members also include BC’s post-secondary institutions such as Emily Carr University of Art + Design, British Columbia Institute of Technology, University of British Columbia and Simon Fraser University.  A full list of Members can be found here.

About the COVID-19 Program:
The COVID-19 Program funds projects that contribute to improving the health and safety of Canadians, supporting Canada’s ability to address issues created by the COVID-19 outbreak.  In addition, these projects will build expertise and capacity to address and anticipate issues that may arise in future health crises. More information can be found here.

For further information, please contact:

Patriot One Inquiries
info@patriot1tech.com

Investor Relations
John Martin, Patriot One
+1 (888) 728-1332
johnm@patriot1tech.com

Media Contacts:
Scott Ledingham, Patriot One
+1-613-806-7135
scott@prmedianow.com

Digital Technology Supercluster
Elysa Darling
587-890-9833

CAUTIONARY DISCLAIMER STATEMENT:
No securities exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release.  This news release contains forward-looking statements relating to system sales, product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects”, “believes”, and similar expressions.  All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties.  There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.  Important factors that could cause actual results to differ materially from the Company's expectations include counterparty default and other risks detailed from time to time in the filings made by the Company with securities regulations.  The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect.  Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company.  The reader is cautioned not to place undue reliance on any forward-looking information.  Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.  Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.  The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements only as expressly required by applicable law.

Neither the Toronto Stock Exchange (TSX) nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring TSX: PAT is a paid for news release on Investorideas.com ($750) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
About Investorideas.com

Sign up for free stock news alerts at Investorideas.com











Get more Covid19 Investor Ideas – news, articles and stock directories 


Friday, June 26, 2020

Investor Ideas Adds Nasdaq IPO’s in Biotech ( $LEGN, $LTRN, $AMTI, $CALT, $RPRX, $PCVX) and Tech ( $UCL, $VRM)


Investor Ideas Adds Nasdaq IPO’s in Biotech ( $LEGN, $LTRN, $AMTI, $CALT, $RPRX, $PCVX) and Tech ( $UCL, $VRM)






Point Roberts WA, Delta BC, June 26, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including biotech and tech.


This week’s new biotech companies are involved in oncology, autoimmune and renal diseases and novel vaccinations.

The latest tech companies include an e-commerce site for automobiles and a telecom data firm from China.

New Stocks added to Biotech stocks directory
Lantern Pharma Inc. (NasdaqGS:LTRN) is a clinical-stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. We leverage advances in machine learning, genomics, and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to respond to our pipeline of cancer therapeutics. Lantern’s focus is to improve the outcome for patients by leveraging our technology to uncover, rescue and develop abandoned or failed drugs. Our current pipeline of three drugs, two in clinical stages and one in preclinical, focuses on cancers that have unique and unmet clinical needs with a clearly defined patient population. We believe that the use of machine learning, genomics and computational methods can help accelerate the revitalization, refocusing and development of small molecule-based therapies. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, this approach represents the potential to deliver best-in-class outcomes. Our team seeks out experienced industry partners, world-class scientific advisors, and innovative clinical-regulatory approaches to assist in delivering cancer therapies to patients as quickly and efficiently as possible.

Legend Biotech Corporation (NasdaqGS:LEGN) is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of over 650 employees across the United States, China and Europe, along with our differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture best-in-class cell therapies for patients in need. We are engaged in a strategic collaboration with Janssen Biotech to develop and commercialize our lead product candidate, LCAR-B38M/JNJ-4528, an investigational BCMA-targeted CAR-T cell therapy for patients living with relapsed or refractory multiple myeloma. This candidate is currently being studied in registrational clinical trials.

Applied Molecular Transport Inc. (NasdaqGS:AMTI) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing oral biologic product candidates in patient-friendly tablet and capsule forms that are designed for either targeting local gastrointestinal (GI) tissue or entering systemic circulation to precisely address the relevant biology of a disease. AMT is building a portfolio of oral product candidates based on its technology platform including its lead product candidate, AMT-101, an oral GI-selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). AMT further plans to initiate Phase 2 clinical trials of AMT-101 in UC and related inflammatory indications. AMT’s technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and RNA therapeutics, with potentially significant advantages over existing marketed and development-stage drugs.

Calliditas Therapeutics AB (NasdaqGS:CALT) is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.

Royalty Pharma plc (NasdaqGS::RPRX) Founded in 1996, Royalty Pharma is a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and three development-stage product candidates.

Vaxcyte, Inc. (NasdaqGS:PCVX) formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).

New Stocks added to Tech stocks directory
uCloudlink Group Inc. (NasdaqGM:UCL) is the world’s first and leading mobile data traffic sharing marketplace, according to Frost & Sullivan, pioneering the sharing economy business model for the telecommunications industry. The Company’s products and services deliver unique value propositions to mobile data users, handset and smart-hardware companies, mobile virtual network operators (MVNOs) and mobile network operators (MNOs). Leveraging its innovative cloud SIM technology and architecture, the Company has redefined the mobile data connectivity experience by allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace, all while providing reliable connectivity, high speeds and competitive pricing.

Vroom, Inc. (NasdaqGS:VRM) is an innovative, end-to-end ecommerce platform designed to offer a better way to buy and a better way to sell used vehicles. The company's scalable, data-driven technology brings all phases of the vehicle buying and selling process to consumers wherever they are and offers an extensive selection of vehicles, transparent pricing, competitive financing, and contact-free, at-home pick-up and delivery.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  


Contact Investorideas.com
800 665 0411